Labiotech.eu

News and Trends 3 Jan 2019

Austrian Biopharma Reaches First HIV Vaccine Milestone

Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T pioneers Gilead Sciences to develop an HIV vaccine using the Austrian company’s arenavirus-based technology. Hookipa’s lead candidate is a prophylactic vaccine for cytomegalovirus, a common infection that can be dangerous in people with weak immune systems, such as those with […]

January 3, 2019 - 2 minutesmins - By Helen Albert

Best in Biotech 31 Dec 2018

European Biotech’s Biggest News of 2018

With this year coming to a close, it’s now time to look back at the biggest biotech news stories of 2018 in Europe, which include CRISPR-Cas9 controversy, big financial deals, and spider silk airplanes. The year 2018 brought a lot of change to the biotech industry in Europe, with clinical trials, approvals and Brexit […]

December 31, 2018 - 12 minutesmins - By Jonathan Smith

Best in Biotech 24 Dec 2018

Looking Back on 2018: Our 10 Most Popular Interviews

As 2018 draws to a close and our thoughts are torn between holiday plans and what the new year may bring, we decided to look back and revisit the people and the stories that attracted our readers the most during the year. These were well received the first time around, so we thought you might […]

December 24, 2018 - 8 minutesmins - By Helen Albert

News and Trends 21 Dec 2018

French Scientists Find a Weak Spot in HIV-Infected Cells

Researchers at the Institut Pasteur were able to selectively kill the cells where HIV hides from antiretroviral drugs, opening the way for a new form of HIV treatments. The reason why HIV comes back when a person stops taking antiretroviral therapy is that it remains hidden and undetected within immune T cells. In a study […]

December 21, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Dec 2018

Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials

A European trial has proved the feasibility and efficacy of treating cancer with a personalized immunotherapy tailored to each patient. The phase I/II trial, run across six European centers, tested a combination of two personalized vaccines in patients with glioblastoma, an aggressive form of brain cancer. The first vaccine was designed to immunize the patients […]

December 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Morphogen IX pulmonary arterial hypertension

More News! 20 Dec 2018

Cambridge Company Raises €20M for Potential First in Lung Disease

Morphogen-IX, based in Cambridge, has raised €20.4M (£18.4M) to fund a new type of treatments for pulmonary arterial hypertension. The Series B financing will go towards the preclinical development of the company’s lead candidate, which has the potential to become the first to treat the condition rather than just addressing the symptoms. People with pulmonary […]

December 20, 2018 - 1 minutemin - By Clara Rodríguez Fernández

Altheia Science gene therapy autoimmune disease

News and Trends 19 Dec 2018

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

Altheia Science, based in Milan, has raised €17M to fund the development of gene therapies for autoimmune diseases with the remarkable potential to be curative. “The success of our fundraising campaign is unprecedented over a Series A in Italy,” said Paolo Rizzardi, co-founder and CEO of Altheia. The funds will go towards taking the company’s […]

December 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Dec 2018

Could We Use CRISPR to Light up Future Christmas Trees?

Scientists in the UK have proposed a way to make bioluminescent Christmas trees using the gene editing tool CRISPR-Cas9. CRISPR-Cas9 is a revolutionary gene editing tool that makes it easier to edit the genome. For this reason, it is now a standard tool in research and development centers worldwide, and companies such as the German chemical […]

December 19, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Dec 2018

Gut Bacteria Could Combat Obesity and Depression

A five-year microbiome project, funded by the EU, has linked the presence of specific strains of gut bacteria to protection from obesity, glucose intolerance, and even depression. The project, called MyNewGut, found evidence that specific strains of bacteria can contribute to obesity in people on high-fat or high-sugar diets. Research led by Yolanda Sanz, Professor […]

December 18, 2018 - 3 minutesmins - By Jonathan Smith

novo nordisk staten fat hypertriglyceridemia cardiovascular disease

News and Trends 17 Dec 2018

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease

Novo Nordisk and the Dutch company Staten Biotechnology will partner to develop a treatment to remove excess fatty molecules called triglycerides from the blood, high levels of which increase a person’s risk for cardiovascular disease. Novo has agreed to pay up to €430M for the worldwide rights to Staten’s candidate drug, as well as the exclusive […]

December 17, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Dec 2018

Series B Boosts British Biotech’s Cell Therapy Automation With €22.6M

The UK company Synthace has raised €22.6M to develop its software platform to automate and improve the manufacturing process in gene and cell therapy. The round, led by Hong Kong-based investor Horizons Ventures, will help to fund the development of Synthace’s software designed to automate key protocols in the lab. Furthermore, the funding will help […]

December 17, 2018 - 2 minutesmins - By Jonathan Smith

More News! 14 Dec 2018

Cultured Meat Company Offers a Taste of the First Lab-Grown Steak

The Israeli company Aleph Farms has shared with the world the first prototype of a beef steak that has been grown in a lab, harming no animal in the process. Although the world’s first lab-grown burger was tasted in 2013, growing a steak had so far remained a challenge. “We are the first company that […]

December 14, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Austrian Biopharma Reaches First HIV Vaccine Milestone

European Biotech’s Biggest News of 2018

Looking Back on 2018: Our 10 Most Popular Interviews

French Scientists Find a Weak Spot in HIV-Infected Cells

Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials

Cambridge Company Raises €20M for Potential First in Lung Disease

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

Could We Use CRISPR to Light up Future Christmas Trees?

Gut Bacteria Could Combat Obesity and Depression

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease

Series B Boosts British Biotech’s Cell Therapy Automation With €22.6M

Cultured Meat Company Offers a Taste of the First Lab-Grown Steak

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!